National Marrow Donor Program (NMDP) and Center for International Blood and Marrow Transplant Research (CIBMTR) – Research Database for Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Clinical Trial Details

The CIBMTR does research with medical data from patients who have had a transplant or other cellular therapy and donors who donate bone marrow or peripheral blood stem cells (PBSCs). The goal of this research is to find ways to make bone marrow and PBSC transplants and other cellular therapies work better.

The CIBMTR is trying to learn more about what makes bone marrow, PBSC and cord blood transplants and other cellular therapies work well. Although the specific study for which your data may be used is not known at this time, the following are types of studies which your data may be included. Studies to:

Determine how well recipients recover from their transplant or cellular therapy
Determine how recovery can be improved after a transplant or cellular therapy
Determine how a donors or recipient’s genetic impact recipient recovery after a transplant or cellular therapy
Determine how to improve different groups of patients access to transplant or cellular therapy
Determine how well donors recover from the collection procedures

Key Eligibility:

Recipient Eligibility Criteria:

Any recipient of an unrelated or related donor or autologous HSC transplant in a CIBMTR center is eligible to participate in the Research Database. This includes adults with and without decision making capacity, and children.

Individual with Marrow Toxic Injury Eligibility Criteria:

Any individual who is treated for a marrow toxic injury at a center participating in the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in the Research Database. This includes adults with and without decision making capacity, and children. Eligible individuals may have received supportive care only, growth factor support, HSC transplant or other appropriate medical treatment for marrow toxic injury. Treatments applied are at the discretion of the care facility, and are not determined by the NMDP or CIBMTR.

Unrelated Donor Eligibility Criteria:

All donors registered on the NMDP Registry who have been requested to donate a product for a recipient are eligible to participate in the Research Database.
All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank Investigational New Drug (IND) protocol, and sign an informed consent document specific to that protocol. Data collected as part of the Cord Blood Bank protocol are included in the Research Database.

Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Ashlee N. Torres, RN
(212) 746-7117
ant9105@med.cornell.edu

Primary Investigator(s)

Tsiporah B Shore, MD (UES)

Protocol ID(s)

Weill Cornell Medicine IRB #:

0211005880

ClinicalTrials.gov:

NCT01166009

Status

Open to Enrollment

Age Group

Adult

Disease

Cancer

Bone Marrow Transplant

Hematologic Malignancies

Solid Tumors